Literature DB >> 30247285

Understanding the Opioid Epidemic: Factors Predictive of Inpatient and Postdischarge Prescription Opioid Use After Orthopaedic Trauma.

Christopher D Flanagan1, Elena F Wysong, James Scott Ramey, Heather A Vallier.   

Abstract

OBJECTIVE: The purpose of this study was to determine which factors influence inpatient and postdischarge opioid use after orthopaedic trauma.
DESIGN: Retrospective cohort study.
SETTING: Single Level 1 trauma center. PARTICIPANTS: The study included 235 adult trauma patients treated operatively for fracture with minimum 1 overnight hospital stay. INTERVENTION: Operative fracture management. MAIN OUTCOME MEASUREMENT: Total opioid pain medication use, in oral morphine equivalents, in inpatient and postdischarge settings.
RESULTS: Controlling for length of stay, inpatient opioid use was negatively correlated with age and positively correlated with Injury Severity Score, intensive care unit (ICU) admission, and baseline tobacco use (P < 0.0001, adjusted R = 0.274). Discharge opioid prescription amount was negatively correlated with age, the presence of a complication, and ICU admission and positively correlated with inpatient opioid use (P < 0.0001, adjusted R = 0.201). Postdischarge opioid use was associated with larger amounts of opioids prescribed at discharge, a patient history of alcohol use at baseline, and ICU admission (P < 0.0001, R = 0.123).
CONCLUSION: Nonmodifiable factors accounted for the level of inpatient opioid use in a trauma population. Higher inpatient use predicts larger opioid prescriptions at discharge, whereas larger discharge prescription predicts greater postdischarge opioid use. Strategies to reduce postdischarge opioid use should begin with reductions in inpatient opioid use. Multimodal pain strategies may be needed to achieve this goal. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30247285     DOI: 10.1097/BOT.0000000000001256

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  7 in total

1.  Pain, Anxiety, and the Continuous Use of Opioids and Benzodiazepines in Trauma Intensive Care Unit Survivors: An Exploratory Study.

Authors:  Carmen Mabel Arroyo-Novoa; Milagros I Figueroa-Ramos; Kathleen A Puntillo
Journal:  P R Health Sci J       Date:  2022-09       Impact factor: 0.600

2.  Regional anesthesia does not decrease opioid demand in pelvis and acetabulum fracture surgery.

Authors:  Daniel J Cunningham; J Patton Robinette; Ariana R Paniagua; Micaela A LaRose; Michael Blatter; Mark J Gage
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-09-14

3.  Long-term opioid use following bicycle trauma: a register-based cohort study.

Authors:  Evelyne Zibung; Erik von Oelreich; Jesper Eriksson; Christian Buchli; Caroline Nordenvall; Anders Oldner
Journal:  Eur J Trauma Emerg Surg       Date:  2022-09-12       Impact factor: 2.374

4.  Are we missing the mark? Relationships of psychosocial issues to outcomes after injury: A review of OTA annual meeting presentations.

Authors:  Natasha M Simske; Mary A Breslin; Sarah B Hendrickson; Heather A Vallier
Journal:  OTA Int       Date:  2020-04-23

5.  Regional anesthesia does not decrease inpatient or outpatient opioid demand in distal femur fracture surgery.

Authors:  Daniel J Cunningham; Ariana R Paniaugua; Micaela A LaRose; Isabel F DeLaura; Michael K Blatter; Mark J Gage
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-03       Impact factor: 2.928

6.  Diagnosis can predict opioid usage and dependence in reverse shoulder arthroplasty.

Authors:  Vani J Sabesan; Arjun Meiyappan; Tyler Montgomery; Charlee Quarless; Ahmed Al-Mansoori; Kiran Chatha
Journal:  JSES Open Access       Date:  2019-11-18

7.  Five-year Trends in Opioid Prescribing Following Orthopaedic Trauma.

Authors:  Christopher D Flanagan; Noah M Joseph; Alex Benedick; Heather A Vallier
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.